Impact of HLA class I functional divergence on HIV control

Area of Science:

• Immunogenetics
• Virology
• Computational Biology

Background:

• Heterozygosity of Human Leukocyte Antigen (HLA) class I genes is associated with better outcomes in HIV infection.
• This is thought to be due to a broader presentation of HIV epitopes and enhanced cytotoxic T cell responses.
• However, the degree of benefit varies among different HLA allotype pairs due to differences in peptide-binding capabilities.

Purpose of the Study:

• To develop a quantitative metric to assess the functional complementarity of peptide-binding profiles between different HLA allotypes.
• To investigate the association between this functional divergence metric and clinical outcomes in HIV infection, specifically AIDS progression and viral load control.

Main Methods:

• Development of a functional divergence metric to measure pairwise complementarity of HLA allotype-associated peptide binding profiles.
• Statistical analysis correlating functional divergence scores for HLA-A and/or HLA-B allotypes with rates of AIDS progression and viral load in HIV-infected individuals.

Main Results:

• Greater functional divergence between pairs of HLA-A and/or HLA-B allotypes was significantly associated with slower progression to AIDS.
• Increased functional divergence was also independently linked to enhanced control of HIV viral load.
• The metric demonstrates predictive power at the peptide-binding level, suggesting a more nuanced understanding of HLA heterozygote advantage.

Conclusions:

• Functional divergence of HLA allotypes is a key factor influencing HIV disease progression and viral control.
• This metric redefines HLA heterozygosity not as a binary state but as a continuum with differential impacts on disease outcomes.
• The concept of functional divergence may have broader implications for understanding immune responses in infections, vaccination, and immunotherapy.